Amoxicillin, the Main Drug for Treating Community-Acquired Pneumonia and Otitis Media, Recommended but Often Not Followed

Background: Amoxicillin is the drug of choice for treating the majority of community-acquired respiratory tract infections in children, including pneumonia and acute otitis media according to both international and national guidelines. Nevertheless, the practice of not following these guidelines is widespread.

Objective: Our aim was to study a range of antibiotics prescribed prior to hospitalization to children with community-acquired pneumonia (CAP) and acute otitis media (AOM), and to evaluate their effectiveness.

Methods. Observational study of children with hospital-verified diagnosis CAP or AOM.

Results. Amoxicillin was prescribed to only 4.5% of children with CAP and 1% of patients with AOM; along with parenteral cephalosporines and amoxicillin/clavulanate in adequate doses therapy was started in 34 and 25% respectively. Other children received 3d generation oral cephalosporines or macrolides, which rendered a very low effectiveness (19 and 10% respectively). In view of a flagrant inconformity of the prescribed antibiotics and their doses to the guidelines, non-effective prescriptions were made for 72% of children with CAP and 69% — with AOM. For children with atypical pneumonia macrolides were prescribed in only 19%.

Conclusion. Since amoxicillin remains the main drug for treating infections caused by an ever increasing number of resistant strains of S. pneumonia and S. pyogenes, it should be prescribed to children with CAP and AOM: its doses (as well as doses of amoxicillin/clavulanate) should be not less than 45 mg/kg/d, and in risk group patients — 80–100 mg/kg/d. The pediatricians’ skills of differentiating atypical pneumonia should be improved.

1. Острые респираторные заболевания у детей. Лечение и профилактика. Научно- практическая программа. — М.: Международный Фонд охраны здоровья матери и ребенка; 2002. — 68 с. [Ostryerespiratornye zabolevaniya u detei. Lechenie i profilaktika. Nauchnoprakticheskaya programma. Moscow: Mezhdunarodnyi Fond okhrany zdorov’ya materi i rebenka; 2002. 68 p. (In Russ).]

2. Козлов Р.С., Сивая О.В., Кречикова О.И. и др. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999–2009 гг. (Результаты многоцентрового проспективного исследования ПеГАС) // Клиническая микробиология и антимикробная химиотерапия. — 2010. — Т. 12. — № 4 — С. 1–13. [Kozlov RS, Sivaya OV, Krechikova OI, et al. Antimicrobial resistance of Streptococcus pneumoniae in Russia over the 1999–2009: results of multicenter prospective study PEHASus. Clinical microbiology and antimicrobial chemotherapy. 2010;12 (4):1–13. (In Russ).]

3. Руководство по амбулаторно-клинической педиатрии / Под ред. Баранова А.А. — М.: ГЭОТАР-Медиа; 2009. — 592 с. [Rukovodstvo po ambulatorno-klinicheskoi pediatrii. Ed by Baranov A.A. Moscow: GEOTAR-Media; 2009. 592 p. (In Russ).]

4. Маянский Н.А., Алябьева Н.М., Иваненко А.М. и др. Бак териальная этиология острого среднего отита у детей до 5 лет: роль Streptococcus pneumoniаe // Вопросы диагностики в педиатрии. — 2013. — Т. 5. — № 3 — С. 5–13. [Mayanskiy NA, Alyabieva NM, Ivanenko AM, et al. Bacterial etiology of acute otitis media in children below 5 years of age: the role of Streptococcus pneumoniаe. Pediatric diagnostics. 2013; 5 (3):5–13. (In Russ).]

5. Калиногородская А.С., Беланов С.С., Волкова М.О. и др. Резистентность к антибиотикам и серотипы Pneumoniae, изолированные у детей в Санкт-Петербурге в 2010–2013 гг. // Антибиотики и химиотерапия. — 2015. — Т. 60. — № 1–2 — С. 10–18. [Kalinogorodskaya AS, Belanov SS, Volkova MO, et al. Antibiotic resistance and serotype pattern of Streptococcus pneumoniae isolated from children in St. Petersburg in 2010– 2013. Antibiot Khimioter. 2015;60 (1–2):10–18. (In Russ).]

6. Баранов А.А., Таточенко В.К, Бакрадзе М.Д. Лихорадящийребенок (протоколы диагностики и лечения). — М.: ПедиатрЪ; 2015. — 288 с. [Baranov AA, Tatochenko VK, Bakradze MD. Likhoradyashchii rebenok (protokoly diagnostiki i lecheniya). Moscow: Pediatr; 2015. 288 p. (In Russ).]

7. Этиопатогенетическая терапия заболеваний верхних дыхательных путей и уха: методические рекомендации / Под ред. С.В. Рязанцева — СПб.: Полифорум Групп; 2015. — 44 с. [Etiopato geneticheskaya terapiya zabolevanii verkhnikh dykhatel’nykh putei i ukha: metodicheskie rekomendatsii. Ed by S.V. Ryazantsev St. Petersburg: Poliforum Grupp; 2015. 44 p. (In Russ).]

8. Внебольничная пневмония у детей. Клинические рекомендации. — М.: Оригинал- макет; 2015. — 64 с. [Vnebol’nichnaya pnevmoniya u detei. Klinicheskie rekomendatsii. Moscow: Originalmaket; 2015. 64 p. (In Russ).]

9. Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):e72–e112. doi: 10.1093/cid/cir1043.

10. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosisand management of acute otitis media. Pediatrics. 2013;131(3):e964–999. doi: 10.1542/peds.2012-3488.

11. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25–76. doi: 10.1093/cid/cir531.

12. infectiologie.com [Internet]. Agence Francaise de Securite Sanitaire des Produits de Sante. Antibiotherapie par voie generale en pratique courante au cours des infections respiratoires basses de l’adulte et de l’enfant. 2005. [cited 2016 Sep 9]. Available from: http://www.infectiologie.com/UserFiles/File/medias/_documents/consensus/2005-infVRB- recos-afssaps.pdf.

13. British Thoracic Society guidelines for the management ofcommunity acquired pneumonia in children: update 2011. Thorax. 2011;66 (Suppl 2):ii1–ii23. doi:10.1136/thoraxjnl-2011-200598.

14. Спичак Т.В., Ким С.С., Катосова Л.К. Критерии диагностики и соответствие лечения внебольничной пневмоний у детей современным стандартам // Вопросы диагностики в педиатрии. — 2010. — Т. 2. — № 6 — С. 31–34. [Spichak TV, Kim SS, Katosova LK. Diagnostic criteria and conformity of treatment for community-acquired pneumonia in children with modern standards. Pediatric diagnostics. 2010;2(6):31–34. (In Russ).]

15. Рачина С.А., Козлов Р.С., Таточенко В.К. и др. Анализ подходов к применению антибиотиков при инфекциях верхних дыхательных путей и ЛОР-органов у детей: результаты опроса участковых педиатров // Клиническая микробиология и антимикробная химиотерапия. — 2016. — Т. 18. — № 1 — С. 20–32. [Rachina SA, Kozlov RS, Tatochenko VK, et al. Paediatricians approach to prescribing of systemic antimicrobials in outpatient children with upper respiratory tract and ENT infections: data from multicenter survey. Clinical microbiology and antimicrobial chemotherapy. 2016;18(1):20– 32. (In Russ).]

16. Рачина С.А., Козлов Р.С., Шаль Е.П. и др. Анализ антибактериальной терапии госпитализированных пациентов с внебольничной пневмонией в различных регионах РФ: уроки многоцентрового фармакоэпидемиологического исследования // Клиническая микробиология и антимикробная химиотерапия. — 2009. — Т.11. — №1 — С. 66–78. [Rachina SA, Kozlov RS, Shal EP, et al. Patterns of antibacterial therapy of community acquired pneumonia in hospitalized adults in different regions of Russia: lessons from multicentre pharmacoepidemiology study. Clinical microbiology and antimicrobial chemotherapy. 2009;11(1):66–78. (In Russ).]

17. Kronman MP, Hersh AL, Feng R, et al. Ambulatory visit rates and antibiotic prescribing for children with pneumoniaе, 1994– 2007. Pediatrics. 2011;127(3):411–418. doi: 10.1542/peds.2010–2008.

18. Neuman MI, Shah SS, Shapiro DJ, Hersh AL. Emergency department management of childhood pneumonia in the United States prior to publication of national guidelines. Acad Emerg Med. 2013;20(3):240–246. doi: 10.1111/acem.12088.

19. Saleh EA, Schroeder DR, Hanson AC, Banerjee R. Guidelineconcordant antibiotic prescribing for pediatric outpatients with otitis media, community-acquired pneumonia, and skin and soft tissue infections in a large multispecialty healthcare system. Clin Res Infect Dis. 2015;2(1):1010.

20. Dubos F, Delvart C, Mordacq C, et al. Evaluation des prescriptions dans la prise en charge des pneumonies aigues communautaires de l’enfant. Arch Pediatr. 2014;21(8):827– 833. doi: 10.1016/j.arcped.2014.05.011.

21. Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology. 2004;9(1):109– 114. doi: 10.1111/j.1440-1843.2003.00522.x.

22. Fischer GW, Bass JW, Arthur JD. Erythromycin for pneumonia — a troublesome recommendation. Pediatrics. 1980;66(1):154–155.

23. Bozdogan B, Appelbaum PC. Macrolide resistance in Streptococci and Haemophilus influenzae. Clin Lab Med. 2004;24(2):455–475. doi: 10.1016/j.cll.2004.03.006.